Your browser doesn't support javascript.
loading
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Stover, Elizabeth H; Oh, Coyin; Keskula, Paula; Choudhury, Atish D; Tseng, Yuen-Yi; Adalsteinsson, Viktor A; Lohr, Jens G; Thorner, Aaron R; Ducar, Matthew; Kryukov, Gregory V; Ha, Gavin; Rosenberg, Mara; Freeman, Samuel S; Zhang, Zhenwei; Wu, Xiaoyun; Van Allen, Eliezer M; Takeda, David Y; Loda, Massimo; Wu, Chin-Lee; Taplin, Mary-Ellen; Garraway, Levi A; Boehm, Jesse S; Huang, Franklin W.
Afiliação
  • Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Oh C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Keskula P; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Choudhury AD; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Tseng YY; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Adalsteinsson VA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Lohr JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Thorner AR; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Ducar M; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Kryukov GV; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Ha G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Rosenberg M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Freeman SS; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Zhang Z; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Wu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Takeda DY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Loda M; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Wu CL; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Taplin ME; Public Health Sciences Division and Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Garraway LA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Boehm JS; Internal Medicine Program, Legacy Health, Portland, Oregon, USA.
  • Huang FW; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Prostate ; 82(5): 584-597, 2022 04.
Article em En | MEDLINE | ID: mdl-35084050
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ácidos Nucleicos Livres Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ácidos Nucleicos Livres Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article